Download
opportunity analysis and industry forecast 2016 n.
Skip this Video
Loading SlideShow in 5 Seconds..
Over the Counter (OTC) Drugs & Dietary Supplements Market- Global Opportunity Analysis and Industry Forecast, 2017-2023 PowerPoint Presentation
Download Presentation
Over the Counter (OTC) Drugs & Dietary Supplements Market- Global Opportunity Analysis and Industry Forecast, 2017-2023

Over the Counter (OTC) Drugs & Dietary Supplements Market- Global Opportunity Analysis and Industry Forecast, 2017-2023

2 Vues Download Presentation
Télécharger la présentation

Over the Counter (OTC) Drugs & Dietary Supplements Market- Global Opportunity Analysis and Industry Forecast, 2017-2023

- - - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - - -
Presentation Transcript

  1. Opportunity Analysis and Industry Forecast, 2016-2023 Over the Counter (OTC) Drugs & Dietary Supplements Market Expected to Reach $335 Million by 2023 Global Opportunity Analysis and Industry Forecast, 2017-2023

  2. Over the Counter (OTC) Drugs & Dietary Supplements Market “Over the counter drugs (OTC) have revolutionized the pharmaceutical and healthcare sector in the past decades, as many prescription medicines have switched to over the counter status. This has proven to be a convenient way for several individuals who prefer self-medications to treat common medical conditions such as, cold, diarrhea, pain, and others. ”

  3. Over the Counter (OTC) Drugs & Dietary Supplements Market Overview According to a new report published by Allied Market Research, titled, Over the Counter (OTC) Drugs & Dietary Supplements Market by Category, Dosage Form, Product, and Distribution Channel: Global Opportunity Analysis and Industry Forecast, 2017-2023," the global over the counter (OTC) drugs & dietary supplements market was valued at $223 million in 2016, and is projected to reach $335 million by 2023, growing at a CAGR of 5.9% from 2017 to 2023. The vitamins and dietary supplements (VDS) segment accounted for maximum share of about half the global market share in 2016. Access Full Summary at: https://www.alliedmarketresearch.com/over-the-counter-OTC-drugs-and-dietary-supplements-market Over the counter (OTC) drugs are basically non-prescription medicines, which are sold without the doctors prescription. Hence, retrieving OTC drugs has become an easy task due to the wide availability of OTC drugs in pharmacies and online health websites. In addition, OTC drugs are regulated by active pharmaceutical ingredients (APIs) and not by the final product. 

  4. Over the Counter (OTC) Drugs & Dietary Supplements Market The global market is driven by improvement in lifestyle & ageing of baby boomers, rise in awareness about general health concerns, and increase in trend among individuals to opt for OTC drugs for self-medication. However, strict regulations by governing bodies, such as FDA, have led to the delayed approval of drugs, restraining the market growth. Conversely, several key players have undertaken R&D activities to enhance OTC drugs for the treatment of various ailments such as laxatives, oral antiseptics, analgesics, and anti-smoking products, providing opportunities for the market players. The cough & cold products segment is expected to grow at a robust CAGR of 6.1% from 2017 to 2023, owing to blockbuster sales of these drugs. As cold & cough is the most commonly acquired ailment among all age groups across the globe, the sales of OTC drugs has increased in the recent years.  

  5. Over the Counter (OTC) Drugs & Dietary Supplements Market, Snapshot The rise in awareness towards personal care and treatment drives the market growth in China. In addition, increase in geriatric population along with the growing incidence of new diseases in this country is expected to supplement the market growth in the near future in China. The report provides a comprehensive analysis of the key players operating in the global market such as Pfizer Inc., Novartis International AG, Roche Holding AG, Merck & Co., Inc., Sanofi S.A, Johnson & Johnson, Gilead Sciences, GlaxoSmithKline plc., Bayer Healthcare AG, and AstraZeneca plc. The other players in the value chain include Alacer Corp., Alcon Inc., Alfresa Pharma Corporation, Alkalon A/S, Alliance Healthcare, Allergan, Plc., Reckitt Benckiser Plc., Bausch & Lomb, AbbVie Inc., and The Colgate-Palmolive Company. 

  6. The study provides an in-depth analysis of the global over the counter (OTC) drugs & dietary supplements market along with the current trends and future estimations to elucidate the imminent investment pockets. • A quantitative analysis from 2016 to 2023 is discussed to enable stakeholders to capitalize on the prevailing market opportunities. • Key market players are profiled and their strategies are thoroughly analyzed to understand the competitive outlook of the industry. • Porters five forces model is expected to interpret the impact of bargaining power of suppliers & buyers, threat of new entrants & substitutes, and competition among the key players on the market growth.  Key Benefits of Over the Counter (OTC) Drugs & Dietary Supplements Market

  7. Over the Counter (OTC) Drugs & Dietary Supplements Market North America Europe Asia-Pacific LAMEA

  8. Over the Counter (OTC) Drugs & Dietary Supplements Market Thank You! For More Details Visit us at https://www.alliedmarketresearch.com/request-sample/2695 Follow Us On